FDA Inspection 1181997 — The Blood Center
The FDA completed an inspection of The Blood Center on Oct 18, 2022 in Slidell, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 18, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Slidell, LA (United States)